Weight-loss drug Wegovy (semaglutide) and its diabetes-focused cousin, Ozempic, have already upended the treatment of both obesity and diabetes, with sales of both drugs skyrocketing.
from Medical Xpress - latest medical and health news stories https://ift.tt/THf3k5z
